Portfolio Updates
PROVEXIS SCIENCE TO BE PUBLISHED IN LEADING SCIENTIFIC JOURNAL
16 May 2006
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces a major international scientific endorsement for its lead product Sirco. Two scientific papers, which detail the clinical efficacy of Sirco, are to be published by the American Journal of Clincial Nutrition (AJCN). The AJCN is internationally recognised as the highest-ranked peer-reviewed journal in the nutrition field.
Sirco, a chilled fruit juice, is the first heart health product to contain the patented Fruitflow technology. Fruitflow is a natural bioactive extract from tomato that works by reducing blood platelet aggregation within hours of cpnsumption. Platelet aggregation plays a significant role in the formation of a thrombus (internal blood clot) which can cuase a heart attack or stroke.
Commenting on the news of the acceptance by the journal, Dr Stephen Franklin, CEO of Provexis, said, "We are delighted that the science behind Fruitflow has been accepted for publicarion by the highest-ranked peer-reviewed scientific journal in the field. We have remained resolute in our belief that the Fruitflow technology is world-class and that this would be recognised by the most stringent scientific review process in the field of clincial nutrition".
"The acceptance of two seperate scientific papers, published in this internationally accredited journal is a significant milestone for the company and an essential precursor to initiating a number of key commercial activities".